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Abstract
In this paper, we study the homogenization of a set of Smoluchowski’s
discrete diffusion-coagulation equations modeling the aggregation and diffu-
sion of β-amyloid peptide (Aβ), a process associated with the development of
Alzheimer’s disease. In particular, we define a periodically perforated domain
Ωǫ, obtained by removing from the fixed domain Ω (the cerebral tissue) infinitely
many small holes of size ǫ (the neurons), which support a non-homogeneous
Neumann boundary condition describing the production of Aβ by the neuron
membranes. Then, we prove that, when ǫ→ 0, the solution of this micro-model
two-scale converges to the solution of a macro-model asymptotically consis-
tent with the original one. Indeed, the information given on the microscale
by the non-homogeneous Neumann boundary condition is transferred into a
source term appearing in the limiting (homogenized) equations. Furthermore,
on the macroscale, the geometric structure of the perforated domain induces a
correction in that the scalar diffusion coefficients defined at the microscale are
replaced by tensorial quantities.
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1 Introduction
The Smoluchowski equation [43] is a system of partial differential equations which
describes the evolving densities of diffusing particles that are prone to coagulate in
pairs [18, 19, 21, 22, 30, 32, 45]. In spite of the large literature concerning the
use of the Smoluchowski equation in many branches of science (e.g. in aerosol
science, polymer science, astrophysics, chemistry), this equation does not seem to
have been considered extensively in the field of biomedical research. Applications of
Smoluchowski equation to the description of the agglomeration of β-amyloid peptide
(Aβ), a process associated with the development of Alzheimer’s disease (AD), seem
to appear for the first time in Murphy and Pallitto [33].
Nowadays, Alzheimer’s disease is the most common form of senile dementia with
enormous socio-economic implications. In recent years, besides in vivo and in vitro
experimental models, there has been an increasing interest in mathematical modeling
and computer simulations (the so-called in silico approach) [1, 6, 16, 20, 24, 41], in
order to better understand the mechanisms for the onset and the evolution of AD. It
is largely accepted that Aβ peptide (especially in soluble form) has a substantial role
in the process of synaptic degeneration leading to neuronal death and eventually to
dementia (the so-called amyloid cascade hypothesis [28]). Aβ, in monomeric form,
is a normal product of cleavage of the amyloid precursor protein (APP), an integral
membrane protein involved in signal transduction pathways. By unknown reasons
(partially genetic), some neurons start to present an imbalance between production
and clearance of Aβ amyloid during aging. Soluble Aβ (in the form of monomers)
diffuses freely through neuronal tissue. At elevated levels, it produces pathological
aggregates (that cannot be readily cleared): long insoluble amyloid fibrils, which
accumulate in spherical deposits known as senile plaques. In addition, it has been
recognised that Aβ is able to initiate an inflammatory response, which implicates
the activation of microglia (the resident immune cells in the central nervous system)
and therefore the release of neurotoxic produtcs that are involved in neuronal and
synaptic damage.
In [33], the authors compare experimental data with numerical simulations based
on the Smoluchowski equation without diffusion, in order to clarify the kinetics of
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conversion of monomeric β-amyloid peptide into macroscopic fibril aggregates. Very
recently, the important role of Smoluchowski equation in modeling the evolution of
AD at different scales has been investigated in [1, 23, 6]. In [1], the authors present
a mathematical model for the aggregation and diffusion of β-amyloid in the brain
affected by AD at a microscopic scale (the size of a single neuron) and at the early
stage of the disease when small amyloid fibrils are free to move and to coalesce. In
the model proposed in [1], a very small portion of the cerebral tissue is described
by a bounded smooth region Ω ⊂ R3, whereas the neurons are represented by a
family of regular disjoint regions Ωj (for 1 ≤ j ≤ M). Moreover, the production
of Aβ in monomeric form at the level of neuron membranes is modeled by a non-
homogeneous Neumann condition on the boundary of Ωj, for j = 1, . . . ,M . On
the other hand, in [6] the authors present a model for the evolution of AD at a
macroscopic scale and over the entire lifetime of the patient. In this case, the whole
brain is represented by a region of the three-dimensional space, and the process of
diffusion and aggregation of Aβ is modeled by a Smoluchowski system with a source
term, coupled with a kinetic-type transport equation that keeps into account the
spreading of the disease. Clearly, at this scale, neurons are no more visible so that
they can be described mathematically as points.
Passing from a microscopic model to a macroscopic one has always been a com-
mon issue in mathematical modeling. As a matter of fact, one wants to start from
differential equations that are assumed to hold on the micro-scale and to transform
them into equations on the macro-scale, by performing a sort of ’averaging process’.
To do that, in the seventies, mathematicians have developed a new method called
homogenization [12, 13, 17]. This method allows to perform certain limits of the
solutions of partial differential equations describing media with microstructures and
to determine equations which the limits are solution of.
In the present work, the homogenization method has been applied to the model
presented in [1], in order to describe the effects of the production and agglomeration
of Aβ on the neuronal scale, at the macroscopic level. In particular, a periodically
perforated domain Ωǫ, obtained by removing from the fixed domain Ω (the cerebral
tissue) infinitely many small holes of size ǫ (the neurons) has been considered. Then,
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a system of Smoluchowski type equations has been defined, in order to describe the
evolution of the β-amyloid peptide with respect to space and time. The production
of Aβ in monomeric form from the neuron membranes has been modeled by coupling
the diffusion-coagulation Smoluchowski equation for the concentration of monomers
with a non-homogeneous Neumann boundary condition on the edge of the holes.
These monomers, growing by binary coalescence, give rise to larger assemblies, which
can diffuse in space with a constant diffusion coefficient, which depends on their size.
It is assumed that, long fibrils, characterized by a very low diffusion, do not coagulate
with each other. We prove that, when ǫ→ 0, the solution of this micro-model two-
scale converges to the solution of a macro-model, where the information given on
the microscale by the non-homogeneous Neumann boundary condition is transferred
into a global source term in the limiting (homogenized) evolution equation for the
concentration of monomers. Moreover, on the macroscale, the geometric structure of
the perforated domain induces a correction in the scalar diffusion coefficients, since
they are replaced by a tensorial quantity with constant coefficients. The peculiarity
of the two-scale convergence method, [3, 4, 5, 7, 14, 15, 25, 26, 27, 34, 36], used
here to study the limiting behavior of the Smoluchowski type equations, is that, in a
single process one can find the homogenized equations and prove the convergence of
a sequence of solutions to the problem at hand. Moreover, while previous approaches
were originally defined only for certain problem classes, two-scale convergence allows
to pass to the limit in all sorts of problems featuring periodic microstructures.
It is noteworthy to outline that most of the models found in the scientific litera-
ture aim to describe AD pathology from a microscopic point of view, exploring events
at the level of single cells or small groups of cells. Typically, the amyloid aggregation
mechanism, the interactions of Aβ deposits, glial cell dynamics, inflammation and
secretion of cytokines are some of the processes more intensively studied, as well as
the stress, recovery and death of neuronal tissue [20]. Only a few models have been
proposed at the macroscale to attempt a description of the evolution and progression
of the disease over the entire lifetime of the patient [6]. The present paper suggests
a possible bridge between these two approaches since, by using the homogenization
theory, we derive a macroscopic model starting from a microscopic one. This issue is
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particularly relevant since it allows to model the onset and progression of the disease
at the proper neuronal scale and then, through an asymptotic procedure, to obtain
consistent macroscopic equations whose outcomes can be directly compared with
the clinical data. In fact, despite the large number of experimental data that can be
extracted from biomedical literature at the microscopic level, all the medical tech-
niques for the evaluation of Alzheimer’s disease operate normally at the macroscale.
Among them, it is worth mentioning:
(i) PIB (Pittsburgh Compound-B)-PET (Positron Emission Tomography) technique
which is used to image β-amyloid plaques in neuronal tissue;
(ii) FDG (Fluoro-Deoxy-D-Glucose)-PET technique which is used to measure cere-
bral metabolic rates of glucose (the decrease of cerebral glucose metabolism largely
precedes the onset of AD symptoms);
(iii) MRI (Magnetic Resonance Imaging) technique which is used to measure struc-
tural tissue loss (i.e., atrophy).
The paper is organized as follows. Section 2 summarizes the main features of
the discrete diffusive Smoluchowski equation, while in Section 3, a mathematical
model describing the self-association and diffusion of β-amyloid peptide (which is the
main trigger of Alzheimer’s disease) is presented. Then, in Section 4, all necessary
mathematical notations are defined and the general assumptions are stated. In
Section 5, we prepare the ground for homogenization by obtaining some a priori
estimates and then we prove our main results. The last section is devoted to some
final remarks.
2 The Smoluchowski equation
The Smoluchowski coagulation equation models various kind of phenomena as for
example: the evolution of a system of solid or liquid particles suspended in a gas (in
aerosol science), polymerisation (in chemistry), aggregation of colloidal particles (in
physics), formation of stars and planets (in astrophysics), red blood cell aggregation
(in hematology), behaviour of fuel mixtures in engines (in engineering), etc. The
original model proposed by Smoluchowski [43] was introduced to describe the binary
coagulation of colloidal particles moving according to Brownian motions and several
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additional physical processes have been subsequently incorporated into the model
(fragmentation, condensation, influence of external fields, see, e.g. [18, 30, 45]). In
view of our subsequent applications, we present the appearance of the Smoluchowski
equation in polymerisation [18, 30, 45]. For k ∈ N, let Pk denote a polymer of size
k, that is a set of k identical particles (monomers). As time advances, the polymers
evolve and, if they approach each other sufficiently close, there is some chance that
they merge into a single polymer whose size equals the sum of the sizes of the two
polymers which take part in this reaction. By convention, we admit only binary
reactions. This phenomenon is called coalescence and we write formally
Pk + Pj −→ Pk+j,
for the coalescence of a polymer of size k with a polymer of size j.
In the model studied further on, we restrict ourselves to the following physical
situation: the approach of two clusters leading to aggregation is assumed to result
only from Brownian movement or diffusion (thermal coagulation). Other effects
such as multiple coagulation or condensation, together with the influence of other
external force fields are neglected. Under these assumptions, the discrete diffusive
coagulation equations read [30, 45]
∂ui
∂t
(t, x) − di △xui(t, x) = Qi(u) in [0, T ] × Ω, (1)
with appropriate initial and boundary conditions.
The variable ui(t, x) ≥ 0 (for i ≥ 1) represents the concentration of i-clusters,
that is, clusters consisting of i identical elementary particles, and
Qi(u) = Qg,i(u) −Ql,i(u) i ≥ 1 (2)












where u = (ui)i≥1. The coagulation rates ai,j are non negative constants such that
ai,j = aj,i and di denotes the diffusion coefficient of an i-cluster, di > 0 ∀i ≥ 1.
The kinetic coefficient ai,j represents reaction in which an (i + j)-cluster is formed
from an i-cluster and a j-cluster. Possible breakup of clusters is not taken into ac-
count. The term Qg,i, given by (3), describes the creation of polymers of size i by
coagulation of polymers of size j and i− j. The term Ql,i, given by (4), corresponds
to the depletion of polymers of size i after coalescence with other polymers. Since
the size of clusters is not limited a priori, Eq. (1) describes a non-linear evolution
equation of infinite dimension, for which even the existence of a local solution is
not guaranteed by the general theory of reaction-diffusion equations. According to
the form of the coalescence kernel ai,j we obtain or not solutions for the system of
equations (1). In general, the coagulation rates are determined by the statistical
probabilities of bond formation and depend upon the details of the physical pro-
cess being considered. If there are no sources nor sinks of clusters in the reactions
described by the initial-boundary value problem (1), the total mass of clusters is
expected to be constant throughout the time evolution of the system, provided it is
initially finite. It turns out however that this property may fail to be true in general
for some physically relevant kinetic coefficients. The break-down of the mass con-
servation is then related to the so-called gelation phenomenon which corresponds to
the appearance of an infinite cluster called gel, caused by the cascading growth of
larger and larger clusters. We will however not consider this issue in the following.
3 A mathematical model for the aggregation and diffu-
sion of β-amyloid peptide
In the present paper, we consider a mathematical model based on the discrete
Smoluchowski equation in order to describe the aggregation and diffusion of β-
amyloid peptide (Aβ) in the brain affected by Alzheimer’s disease (AD) [1]. Aβ
is naturally present in the brain and cerebrospinal fluid of humans throughout life,
even if its role is currently unknown. By now, it is recognized that the mere presence
of Aβ in the brain is not sufficient to support the diagnosis of AD. Neuronal injury
is rather the result of ordered Aβ self-association [9, 20, 31, 35, 39, 46]. The amyloid
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plaques, which serve as a hallmark for AD, have been found to contain large amounts
of Aβ organized into amyloid fibrils. There is no clear correlation, however, between
the presence of the Aβ containing plaques in the brain and the severity of AD
neurodegeneration. Therefore, in recent years, the research in this area has shifted
its focus from senile plaques toward oligomeric conformations of Aβ. This oligomeric
form of Aβ is highly toxic to the brain and is the trigger for loss of synapses and
neuronal damage. However, the transient nature of small oligomeric aggregates
makes it difficult to shed light on their formation process or structure. Most proposed
pathways for the initial stages of Aβ amyloid fibril formation amount to a sequence
of events that can be summarized as follows: unordered monomeric Aβ in solution
converts into an ‘activated’ monomer that then recruits other Aβ molecules to form
oligomers. The length-wise association of individual protofibrils produces the mature
amyloid fibrils, whose structure has been studied in most detail due to their high
stability under a wide range of physicochemical conditions. The mature fibrillar
form and monomeric Aβ have both been confirmed on many occasions as the only
non-toxic species.
In the present work, we discard fibril fragmentation, which can be considered as
a secondary process in the mechanism of amyloid self-assembly (for a model with
fragmentation, we refer to [23]). In the mathematical model proposed in [1] and
reported below, the authors consider a portion of the hippocampus or of the cerebral
cortex (the regions of the brain mainly affected by AD) whose size is comparable
to a multiple of the size of a neuron, thus avoiding the description of intracellular
phenomena. With this choice of scale, it is coherent to consider that the diffusion
is uniform. Moreover, it is assumed that ‘large’ assemblies do not aggregate with
each other. This assumption prevents blow-up phenomena for solutions at a finite
time, but it is also consistent with experimental data [20, 33]. The portion of
cerebral tissue considered in the following is represented by a bounded smooth region
Ω0 ⊂ R3, whereas the neurons are represented by a family of regular regions Ωj such
that
(i) Ωj ⊂ Ω0 if j = 1, 2, . . . ,M ;
(ii) Ωi ∩ Ωj = ∅ if i 6= j.
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Let us set




and consider a vector-valued function u = (u1, . . . , uM ), where M ∈ N and uj =
uj(t, x), t ∈ R, t ≥ 0 (the time), and x ∈ Ω. If 1 ≤ j < M − 1, then uj(t, x) is
the (molar) concentration at the point x and at the time t of an Aβ assembly of j
monomers, while uM takes into account aggregations of more than M−1 monomers.
The production of Aβ in the monomeric form at the level of neuron membranes is
modeled by a non-homogeneous Neumann condition on ∂Ωj , the boundary of Ωj,
for j = 1, . . . ,M . Finally, an homogeneous Neumann condition on ∂Ω0 is meant to
artificially isolate the portion of tissue considered from its environment. Thus, the






(t, x) − d1 △xu1(t, x) + u1(t, x)
∑M
j=1 a1,juj(t, x) = 0
∂u1
∂ν
≡ ∇xu1 · n = 0 on ∂Ω0
∂u1
∂ν
≡ ∇xu1 · n = ψj on ∂Ωj, j = 1, . . . ,M
u1(0, x) = U1 ≥ 0
(5)
where 0 ≤ ψj ≤ 1 is a smooth function for j = 1, . . . ,M describing the production
of the amyloid near the membrane of the neuron. Indeed, the experimental evidence
shows that the production of Aβ is not uniformly distributed over the neuronal
cells. This localization of the production is expressed by means of the choice of
the functions ψj. Moreover, only the neurons affected by the disease are taken into
account, i.e. it is assumed ψj 6= 0 for j = 1, . . . ,M .







(t, x) − dm △xum(t, x) + um(t, x)
∑M







≡ ∇xum · n = 0 on ∂Ω0
∂um
∂ν
≡ ∇xum · n = 0 on ∂Ωj, j = 1, . . . ,M
















≡ ∇xuM · n = 0 on ∂Ω0
∂uM
∂ν
≡ ∇xuM · n = 0 on ∂Ωj, j = 1, . . . ,M
uM (0, x) = 0
(7)
For reasons related to the model, we can assume that the diffusion coefficients dj > 0,
j = 1, . . . ,M , are small when j is large, since big assemblies do not move. The
coagulation rates aij are symmetric aij = aji > 0, i, j = 1, . . . ,M , but aMM = 0.
Let us remark that the meaning of uM differs from that of um, m < M , since it
describes the sum of the densities of all the ‘large’ assemblies. It is assumed that
large assemblies exhibit all the same coagulation properties and do not coagulate
with each other. Indeed, the present model only takes into account the evolution
of the Aβ and ignores the role played by the microglia and astrocytes in neuronal
death and in the formation of senile plaques.
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4 Setting of the problem
Let Ω be a bounded open set in R3 with a smooth boundary ∂Ω. Let Y be the
unit periodicity cell [0, 1[3 having the paving property. We perforate Ω by removing
from it a set Tǫ of periodically distributed holes defined as follows. Let us denote
by T an open subset of Y with a smooth boundary Γ, such that T ⊂ IntY . Set
Y ∗ = Y \T which is called in the literature the solid or material part. According to
the model presented in Section 3, the set T represents a generic neuron, and Y ∗ the
supporting cerebral tissue. We define τ(ǫT ) to be the set of all translated images of
ǫT of the form ǫ(k + T ), k ∈ Z3. Then,
Tǫ := Ω ∩ τ(ǫT ).
Introduce now the periodically perforated domain Ωǫ defined by
Ωǫ = Ω \ T ǫ.
For the sake of simplicity, we make the following standard assumption on the
holes [13, 17]: there exists a ‘security’ zone around ∂Ω without holes, i.e.
∃ δ > 0 such that dist (∂Ω, Tǫ) ≥ δ. (8)
Therefore, Ωǫ is a connected set ([13]). The boundary ∂Ωǫ of Ωǫ is then composed of
two parts. The first one is the union of the boundaries of the holes strictly contained
in Ω. It is denoted by Γǫ and is defined by
Γǫ := ∪
{
∂(ǫ(k + T )) | ǫ(k + T ) ⊂ Ω
}
.
The second part of ∂Ωǫ is its fixed exterior boundary denoted by ∂Ω. It is easily
seen that (see [4], Eq. (3))
lim
ǫ→0




where | · |N is the N -dimensional Hausdorff measure.
Throughout this paper, ǫ will denote the general term of a sequence of positive
reals which converges to zero.












j = 0 in [0, T ] × Ωǫ
∂uǫ1
∂ν
≡ ∇xuǫ1 · n = 0 on [0, T ] × ∂Ω
∂uǫ1
∂ν
≡ ∇xuǫ1 · n = ǫ ψ(t, x, xǫ ) on [0, T ] × Γǫ
uǫ1(0, x) = U1 in Ωǫ
(10)
where ψ is a given bounded function satisfying the following conditions:
(i) ψ(t, x, xǫ ) ∈ C1(0, T ;B) with B = C1[Ω;C1#(Y )], where C1#(Y ) is the subset of
C1(RN ) of Y -periodic functions;
(ii) ψ(t = 0, x, xǫ ) = 0
and U1 is a positive constant such that
U1 ≤ ‖ψ‖L∞(0,T ;B). (11)
Beyond the regularity properties mentioned above, ψ is a generic given function
that should be specified in some way, if one has the ambition to make the model
applicable. In general, if one wishes to emphasize simply a functional dependence
of ψ which mimics the medical observations about the space-time distribution of
Aβ produced by damaged neurons, a possible choice is the following: ψ(t, x, xǫ ) =
ψ0(
x
ǫ )ψ1(t− g(x)), where the function ψ1(s) ≡ 0 for s near 0 and ψ1(s) ≡ 1 for large
s > 0. The function g takes into account that different cerebral regions are affected
at different times. In the last section, it is suggested another more explicit formal
expression for the function ψ, in an attempt to create a link between the model
presented here and the one described in [6], for which numerical simulations have
been carried out.
















m · n = 0 on [0, T ] × ∂Ω
∂uǫm
∂ν
≡ ∇xuǫm · n = 0 on [0, T ] × Γǫ







∂t − div(dM ∇xu
ǫ
M ) = g
ǫ in [0, T ] × Ωǫ
∂uǫM
∂ν
≡ ∇xuǫM · n = 0 on [0, T ] × ∂Ω
∂uǫM
∂ν
≡ ∇xuǫM · n = 0 on [0, T ] × Γǫ
uǫM (0, x) = 0 in Ωǫ
(13)























Theorem 4.1. If ǫ > 0 the system (10) - (13) has a unique solution
(uǫ1, . . . , u
ǫ
M ) ∈ C1+α/2,2+α([0, T ] × Ωǫ) (α ∈ (0, 1))
such that
uǫj(t, x) > 0 for (t, x) ∈ (0, T ) × Ωǫ, j = 1, . . . ,M .
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Proof. The proof can be carried out as in [1], using Theorem 1, p.111 of [42] for the







− div(d1 ∇xgǫ) = 0 in [0, T ] × Ωǫ
∂gǫ
∂ν
≡ ∇xgǫ · n = 0 on [0, T ] × ∂Ω
∂gǫ
∂ν
≡ ∇xgǫ · n = ǫ ψ(t, x, xǫ ) on [0, T ] × Γǫ
gǫ(0, x) = 0 in Ωǫ.
Notice that the function gǫ is bounded in [0, T ] × Ωǫ, uniformly with respect to
ǫ > 0. This can be proven, for instance, following the arguments used in the proof
of Lemmas 5.1 and 5.2.
Our aim is to study the homogenization of the set of equations (10)-(13) as ǫ→ 0,
i.e., to study the behaviour of uǫj(1 ≤ j ≤ M) as ǫ→ 0 and obtain the equations
satisfied by the limit. There is no clear notion of convergence for the sequence
uǫj(1 ≤ j ≤M) which is defined on a varying set Ωǫ. This difficulty is specific to the
case of perforated domains. A natural way to get rid of this difficulty is given by
Nguetseng-Allaire two-scale convergence [3, 36].
5 Homogenization of the Smoluchowski equation
5.1 Presentation of the main results
Theorem 5.1. Let uǫm(t, x) (1 ≤ m ≤M) be a family of classical solutions to prob-
lems (10)-(13). The sequences ũǫm and ∇̃xuǫm (1 ≤ m ≤ M) two-scale converge to:
[χ(y)um(t, x)] and [χ(y)(∇xum(t, x) + ∇yu1m(t, x, y))] (1 ≤ m ≤ M), respectively,
where tilde denotes the extension by zero outside Ωǫ and χ(y) represents the charac-
teristic function of Y ∗. The limiting functions (um(t, x), u
1
m(t, x, y)) (1 ≤ m ≤ M)
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are the unique solutions in L2(0, T ;H1(Ω))×L2([0, T ]×Ω;H1#(Y )/R) of the following
two-scale homogenized systems.










+ θ u1(t, x)
∑M




ψ(t, x, y) dσ(y) in [0, T ] × Ω
[A∇xu1(t, x)] · n = 0 on [0, T ] × ∂Ω
u1(0, x) = U1 in Ω
(16)










+ θ um(t, x)
∑M
j=1 am,j uj(t, x)
= θ2
∑m−1
j=1 aj,m−juj(t, x)um−j(t, x) in [0, T ] × Ω
[A∇xum(t, x)] · n = 0 on [0, T ] × ∂Ω
um(0, x) = 0 in Ω
(17)






(t, x) − divx
[







aj,k uj(t, x)uk(t, x) in [0, T ] × Ω
[A∇xuM (t, x)] · n = 0 on [0, T ] × ∂Ω














χ(y)dy = |Y ∗|





(∇ywi + êi) · (∇ywj + êj) dy





−divy[∇ywi + êi] = 0 in Y ∗
(∇ywi + êi) · n = 0 on Γ
y → wi(y) Y − periodic
(19)
5.2 Preliminary a priori estimates
Since the homogenization will be carried out in the framework of two-scale con-
vergence, we first need to obtain the a priori estimates for the sequences uǫj , ∇uǫj,
∂tu
ǫ






by the classical maximum principle [40] the following estimate holds.
Lemma 5.1. Let T > 0 be arbitrary and uǫ1 be a classical solution of (10). Then,
‖uǫ1‖L∞(0,T ;L∞(Ωǫ)) ≤ |U1| + ‖u
ǫ
1‖L∞(0,T ;L∞(Γǫ)). (20)
Thus, the boundedness of uǫ1(t, x) in L
∞([0, T ] × Γǫ), uniformly in ǫ, can be
immediately deduced from Lemma 5.2 below.
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Lemma 5.2. Let T > 0 be arbitrary and uǫ1 be a classical solution of (10). Then,
‖uǫ1‖L∞(0,T ;L∞(Γǫ)) ≤ c ‖ψ‖L∞(0,T ;B) (21)
where c is independent of ǫ.
In order to establish Lemma 5.2, we will first need the following preliminary
results [29, 37].
Lemma 5.3 ([29], Lemma 5.6). Let (z̃n)n∈N0 be a sequence of non-negative real
numbers such that
z̃n+1 ≤ c bn z̃r/2n (22)










z̃n ≤ θ b−nN (24)
for all n ∈ N0.
Theorem 5.2. Assume that there exist positive constants T , k̂ = ‖ψ‖L∞(0,T ;B), γ,
such that for all k ≥ k̂ we have





















1(t, x) ≤ 2mk̂ (26)
where the positive constant m is independent of ǫ.
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Let M ≥ k̂ be arbitrary and define








for all n ∈ N0. We prove that the sequence (zn) satisfies the assumptions of Lemma
5.3. To this end, let n ∈ N0 be fixed. From the trivial estimate


















Hence, since the condition (27) holds, by using (120) we obtain
2−2(n+1) M2 zn+1 = (kn+1 − kn)2 zn+1
≤ c ǫ2/r ǫ−N−[
2(1−N)
r
] ‖u(kn)ǫ ‖2Qǫ(T )
(31)
where c is a positive constant independent of ǫ. Therefore,
2−2(n+1) M2 zn+1 ≤ c ǫ−
N
(1+N) ‖u(kn)ǫ ‖2Qǫ(T ) (32)
Moreover, from (25) and (28) we get
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n ≤ γ (2 − 2−n)2 M2 zr/2n
≤ 4 γM2 zr/2n
(33)
Combining (32) and (33), we obtain
zn+1 ≤ c0 ǫ−
N
(1+N) 22 n zr/2n (34)











M := k̂ + λ−1/r
√
c′ k̂ ≡ mk̂ (35)
where c′ is defined in (36) and m > 1. Now we want to estimate z0 for the fixed
value of M given by (35). From the definition (28) and (9), by following the same
strategy which leads to (32) and (33), where we substitute k̂ for kn and M for kn+1,
we have
(M− k̂)2 z0 ≤ c ǫ−
N

































z̃n+1 ≤ c0 22n ǫ−1 z̃r/2n
z̃0 ≤ λ2/r = (c0)−N 2−2N
2
(40)
Keeping in mind (40), it is easy to see that the sequence (z̃n) satisfies the assumptions







and b := 4.
Therefore, in view of Lemma 5.3, one can conclude that zn → 0 as n → ∞, which
implies
uǫ1 ≤ limn→∞ kn = 2M
almost everywhere on Γǫ for almost every t ∈ [0, T ] if we define M as in (35). This
gives (26).
Proof of Lemma 5.2. Let T > 0 and k ≥ 0 be fixed. Define: u(k)ǫ (t) := (uǫ1(t) − k)+







∇xu(k)ǫ = ∇xuǫ1 1{uǫ1>k}. (42)
Moreover,
u(k)ǫ |∂Ω= (uǫ1 |∂Ω −k)+ (43)
u(k)ǫ |Γǫ= (uǫ1 |Γǫ −k)+ (44)
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Let us assume k ≥ k̂, where k̂ := ‖ψ‖L∞(0,T ;B). Then, by (11),
uǫ1(0, x) = U1 ≤ k̂ ≤ k. (45)






















































































u(k)ǫ (s) dσǫ(x) − d1
∫
Ωǫ






















































where we denote by Aǫk(t) and B
ǫ
k(t) the set of points in Ωǫ and on Γǫ, respectively,
at which uǫ1(t, x) > k. It holds:
|Aǫk(t)| ≤ |Ωǫ|
|Bǫk(t)| ≤ |Γǫ|
with | · | being the natural Hausdorff measure.
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Introducing the following norm



























































|u(k)ǫ (t)|2 dx ≤ ‖u(k)ǫ ‖2Lr1(0,T1;Lq1 (Ωǫ)) ‖1Aǫk‖Lr′1 (0,T1;Lq′1 (Ωǫ)) (51)
with r′1 =
r1




q1 − 1, r1 = 2 r1, q1 = 2 q1, where, for N > 2, r1 ∈ (2,∞)









In particular, r′1, q
′































































































Hence, by Theorem 5.2 we obtain
‖uǫ1‖L∞(0,T1;L∞(Γǫ)) ≤ 2mk̂
where the positive constant m is independent of ǫ. Analogous arguments are valid








and Tp ≡ T . Thus, after a finite number of steps, we obtain the estimate (21).
Lemma 5.4. The sequence ∇xuǫ1 is bounded in L2([0, T ] × Ωǫ), uniformly in ǫ.
Proof. Let us multiply the first equation in (10) by the function uǫ1(t, x). Integrating,



























































)|2 dσǫ(x) ≤ C2 ‖ψ(t)‖2B (58)
where C2 is a positive constant independent of ǫ and B = C
1[Ω;C1#(Y )]. Therefore,














since the third term on the left-hand side of (56) is non-negative. Integrating over
[0, t] with t ∈ [0, T ], we get







|∇xuǫ1|2 dx ≤ C3 + d1 C1 ‖uǫ1‖2L2(0,T ;L2(Ωǫ))
(60)
where C1 and C3 are positive constants independent of ǫ since, by (11),
uǫ1(0, x) = U1 ≤ ‖ψ‖L∞(0,T ;B).
Taking into account that the first term on the left-hand side of (60) is non-negative
and the sequence uǫ1 is bounded in L
∞(0, T ;L∞(Ωǫ)), one has
d1 (2 − ǫ2C1) ‖∇xuǫ1‖2L2(0,T ;L2(Ωǫ)) ≤ C4 (61)
Thus the boundedness of ∇xuǫ1(t, x) follows, provided that ǫ is close to zero.
Lemma 5.5. Let uǫm(t, x) (1 < m < M) be a classical solution of (12). Then
‖uǫm‖L∞(0,T ;L∞(Ωǫ)) ≤ Km (62)
uniformly with respect to ǫ, where








Proof. The Lemma can be proved directly by induction following the same argu-
ments presented in [45] (Lemma 2.2, p. 284). Since we have a zero initial condition
for the system (12), we have chosen a function slightly different than what was done
in [45] to test the mth equation of (12):
φm ≡ p (uǫm)(p−1) p ≥ 2.
We stress that the functions φm are strictly positive and continuously differentiable
in [0, t] × Ω, for all t > 0. The rest of the proof carries over verbatim.
Lemma 5.6. The sequence ∇xuǫm (1 < m < M) is bounded in L2([0, T ] × Ωǫ),
uniformly in ǫ.
Proof. Let us multiply the first equation in (12) by the function uǫm(t, x). By the
divergence theorem and Hölder’s inequality, exploiting the boundedness of uǫj(t, x)










|∇xuǫm|2 dx ≤ C3 ‖uǫm(t, ·)‖L2(Ωǫ) (64)
where C3 is a constant which does not depend on ǫ. Dividing by ‖uǫm(t, ·)‖L2(Ωǫ)












|∇xuǫm|2 dx ≤ C3 T (65)
exploiting the boundedness of uǫm(t, x) in L
∞(0, T ;L∞(Ωǫ)). Hence






|∇xuǫm|2 dx ≤ C5 (66)
where C4 and C5 are positive constants independent of ǫ. Then, the boundedness of
∇xuǫm(t, x) in L2([0, T ] × Ωǫ), uniformly in ǫ, follows immediately from (66).
Lemma 5.7. Let uǫM (t, x) be a classical solution of (13). Then
‖uǫM‖L∞(0,T ;L∞(Ωǫ)) ≤ KM (67)
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with the constants Kj (1 < j < M) given by (63).
Proof. Let us test the first equation of (13) with the function
φM ≡ p (uǫM )(p−1) p ≥ 2.
The function φM is strictly positive and continuously differentiable in [0, t] × Ω, for



































































































(p−1) dx =: I3
(71)
In order to estimate I3, it is now convenient to use Young’s inequality in the following
form [8]:
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a b ≤ η ap′ + η1−p bp ∀a ≥ 0, b ≥ 0 (72)




































































ds p ‖uǫM (s)‖pLp(Ωǫ) (75)


























Lemma 5.8. The sequence ∇xuǫM is bounded in L2([0, T ] × Ωǫ), uniformly in ǫ.
The proof of Lemma 5.8 is achieved by applying exactly the same arguments
considered in the proof of Lemma 5.6.
27
Lemma 5.9. The sequence ∂tu
ǫ
j (1 ≤ j ≤ M) is bounded in L2([0, T ] × Ωǫ), uni-
formly in ǫ.
Proof. Case j = 1: let us multiply the first equation in (10) by the function ∂tu
ǫ
1(t, x).
By the divergence theorem, by Hölder’s and Young’s inequalities, exploiting the







































|∇xuǫ1(t, x)|2 dx ≤ C1 T




























t = 0, x, xǫ
)
≡ 0. Taking into account the inequalities (57)-(58) and Lemma











dx+ d1(1 − ǫ2C3)
∫
Ωǫ
|∇xuǫ1|2 dx ≤ C1 T +C4 + C7 (80)
where the positive constants C1, C3, C4, C7 are independent of ǫ, since ψ ∈ L∞(0, T ;B),
uǫ1 is bounded in L












dσǫ(x) ≤ C̃ ‖∂tψ(t)‖2B ≤ C5
with C̃ and C5 independent of ǫ. For a sequence ǫ of positive numbers going to zero:
(1− ǫ2C3) ≥ 0. Then, the second term on the left-hand side of (80) is non-negative,
and one has
‖∂tuǫ1‖2L2(0,T ;L2(Ωǫ)) ≤ C (81)
where C ≥ 0 is a constant independent of ǫ.
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Case 1 < j < M : let us multiply the first equation in (12) by the function
∂tu
ǫ
m(t, x). By the divergence theorem, by Hölder’s and Young’s inequalities, ex-













|∇xuǫm|2 dx ≤ 2C1 + C2 (82)














|∇xuǫm(t, x)|2 dx ≤ C3 T (83)
Since the second term on the left-hand side of (83) is non-negative, we conclude that
‖∂tuǫm‖2L2(0,T ;L2(Ωǫ)) ≤ C (84)
where C ≥ 0 is a constant independent of ǫ.
By applying exactly the same arguments considered in proving the boundedness
of ∂tu
ǫ
j(t, x) (1 < j < M) in L
2(0, T ;L2(Ωǫ)), one can derive also the following
estimate
‖∂tuǫM‖2L2(0,T ;L2(Ωǫ)) ≤ C (85)
where C ≥ 0 is a constant independent of ǫ.
5.3 Proof of the main theorem
Let us now come back to the proof of the main results stated in Theorem 5.1. In
view of Lemmas 5.1-5.2 and 5.4-5.8 the sequences ũǫm and ∇̃xuǫm (1 ≤ m ≤ M) are
bounded in L2([0, T ]×Ω), and by application of Theorem B.1 and Theorem B.3 they
two-scale converge, up to a subsequence, to: [χ(y)um(t, x)] and [χ(y)(∇xum(t, x) +






(1 ≤ m ≤ M) two-scale converges to:
[
χ(y) ∂um∂t (t, x)
]
(1 ≤ m ≤M).
We can now find the homogenized equations satisfied by um(t, x) and u
1
m(t, x, y)
(1 ≤ m ≤M).
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In the case m = 1, let us multiply the first equation of (10) by the test function


















































































ψ(t, x, y)φ(t, x) dt dx dσ(y).
(87)
The last term on the left-hand side of (87) has been obtained by using Theorem B.2,
while the term on the right-hand side has been attained by application of Theorem
B.5. An integration by parts shows that (87) is a variational formulation associated
to the following homogenized system:
−divy[d1(∇xu1(t, x) + ∇yu11(t, x, y))] = 0 in [0, T ] × Ω × Y ∗ (88)









(∇xu1(t, x) + ∇yu11(t, x, y))dy
]
+ θ u1(t, x)
M∑
j=1
a1,j uj(t, x) − d1
∫
Γ





(∇xu1(t, x) + ∇yu11(t, x, y)) dy
]





χ(y)dy = |Y ∗|
is the volume fraction of material. To conclude, by continuity, we have that
u1(0, x) = U1 in Ω.
Taking advantage of the constancy of the diffusion coefficient d1, Eqs. (88) and (89)
can be reexpressed as follows
△yu11(t, x, y) = 0 in [0, T ] × Ω × Y ∗ (92)
∇yu11(t, x, y) · n = −∇xu1(t, x) · n on [0, T ] × Ω × Γ (93)
Then, u11(t, x, y) satisfying (92)-(93) can be written as











−divy[∇ywi + êi] = 0 in Y ∗
(∇ywi + êi) · n = 0 on Γ
y → wi(y) Y − periodic
(95)















ψ(t, x, y) dσ(y) = 0 in [0, T ] × Ω
(96)
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[A∇xu1(t, x)] · n = 0 on [0, T ] × ∂Ω (97)




(∇ywi + êi) · (∇ywj + êj) dy.
In the case 1 < m < M , let us multiply the first equation of (12) by the test
function














































m−j φǫ dt dx
(98)








































aj,m−j uj(t, x)um−j(t, x)φ(t, x) dt dx dy.
(99)
The last term on the left-hand side of (99) and the term on the right-hand side have
been obtained by using Theorem B.2. An integration by parts shows that (99) is a
variational formulation associated to the following homogenized system:
−divy[dm(∇xum(t, x) + ∇yu1m(t, x, y))] = 0 in [0, T ] × Ω × Y ∗ (100)
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(∇xum(t, x) + ∇yu1m(t, x, y))dy
]
+ θ um(t, x)
M∑
j=1









(∇xum(t, x) + ∇yu1m(t, x, y)) dy
]





χ(y)dy = |Y ∗|
is the volume fraction of material. Moreover, by continuity
um(0, x) = 0 in Ω.
Taking advantage of the constancy of the diffusion coefficient dm, Eqs. (100) and
(101) can be reexpressed as follows
△yu1m(t, x, y) = 0 in [0, T ] × Ω × Y ∗ (104)
∇yu1m(t, x, y) · n = −∇xum(t, x) · n on [0, T ] × Ω × Γ (105)
Then, u1m(t, x, y) satisfying (104)-(105) can be written as











−divy[∇ywi + êi] = 0 in Y ∗
(∇ywi + êi) · n = 0 on Γ
y → wi(y) Y − periodic
(107)
33
















aj,m−j uj(t, x)um−j(t, x) = 0 in [0, T ] × Ω
(108)
[A∇xum(t, x)] · n = 0 on [0, T ] × ∂Ω (109)




(∇ywi + êi) · (∇ywj + êj) dy.
The proof for the casem = M is achieved by applying exactly the same arguments
considered when 1 < m < M .
Theorem 5.1 shows that the macroscale (homogenized) model, obtained from Eqs.
(10)-(13) as ǫ→ 0, is asymptotically consistent with the original model and resolves
both the coarse and the small scale. The information given on the micro-scale, by
the non-homogeneous Neumann boundary condition in (10), is transferred into the
source term in the first equation of (16), describing the limit model. Furthermore,
on the macro-scale, the geometric structure of the perforated domain induces a
correction in that the scalar diffusion coefficients di (1 ≤ i ≤ M), defined at the
microscale, are replaced by a tensorial quantity with constant coefficients.
6 Final remarks
Alzheimer disease is characterized pathologically by the formation of senile plaques
composed of the amyloid-β (Aβ) peptide. In the present paper, we analyze a set
of Smoluchowski’s discrete diffusion-coagulation equations modeling the aggregation
and diffusion of Aβ. In particular, the information given on the micro-scale, by the
non-homogeneous Neumann boundary condition in (10), describing the production
of Aβ in monomeric form by the damaged neurons, is transferred, using the homoge-
nization theory, into the global source term which appears in the limit equation (16).
This model can be related to the one introduced in [6], where the process of diffusion
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and agglomeration of Aβ is described on the macro-scale by a Smoluchowski system
with a source term, coupled with a kinetic-type transport equation for the distri-
bution function of the degree of malfunctioning of neurons that keeps into account
the spreading of the disease through a neuron-to-neuron prion-like transmission. In
particular, the mathematical analysis carried out in this paper can be regarded as
a formal derivation (that is, neglecting regularity issues), starting from the micro-
scale, of the source term F , introduced ad hoc in the second equation of (2.16) in
[6], in order to describe the production of Aβ in monomeric form by neurons. A
comparison between the model equation (16) and the second equation of (2.16) in
[6] allows us to make the following choice of the function ψ(t, x, y) appearing in (16):
ψ(t, x, y) = CF
∫ 1
0




g(y) dσ(y) = const.
In Eq. (110), the parameter a ∈ [0, 1] describes the degree of malfunctioning of a
neuron: a close to 0 stands for ’the neuron is healthy’ whereas a close to 1 for ’the
neuron is dead’. Given x ∈ Ω, t ≥ 0 and a ∈ [0, 1],
f(x, a, t) da
indicates the fraction of neurons close to x with degree of malfunctioning at time t
between a and a+ da. Furthermore, the small constant µ0 > 0 in (110) accounts for
Aβ production by healthy neurons. In [6], an evolution equation for the distribution
function f has been proposed:
∂tf + ∂a(f v[f ]) = J [f ] (111)





K(x, a, y, b)f(y, b, t) dy db. (112)
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The integral term describes the possible prion-like propagation of AD through the
neural pathway. Malfunctioning neighbours are harmful for a neuron’s health state,
while healthy ones are not:
K(x, a, y, b) ≥ 0 ∀x, y ∈ Ω, a, b ∈ [0, 1],
K(x, a, y, b) = 0 if a > b.
The term J [f ] in (111) accounts for the onset of AD, since it is written in terms
of the probability that, in randomly chosen parts of the cerebral tissue, the degree of
malfunctioning of neurons randomly jumps to higher values due to external agents
or genetic factors. What prevents our homogenization results from being considered
a fully rigorous derivation of the source term F , appearing in the second equation of
(2.16) in [6], is the fact that the solutions of Eq. (111) do not satisfy, in general, all
the regularity properties assumed on ψ. However, Eq. (110) allows us to establish a
link, at least formally, between the limit model derived here and the one presented in
[6], suggesting a possible choice for ψ, considered, in the present paper, as a generic
given function.
It is worth noting that the plots of f , at different times, can be directly com-
pared with medical Fluorodeoxyglucose PET images [6]. The numerical simulations
reported in [6] are in good qualitative agreement with clinical images of the disease
distribution in the brain which vary from early to advanced stages.
A Appendix A












where C1 is a constant which does not depend on ǫ.
The inequality (113) can be easily obtained from the standard trace theorem by
means of a scaling argument [4, 10, 11].
Lemma A.2. Suppose that the domain Ωǫ is such that assumption (8) is satisfied.




and a constant C > 0 independent of ǫ such that














for each v ∈W 1,p(Ωǫ) and for any p ∈ (1,+∞).
For the proof of this Lemma see for instance [10].
As a consequence of the existence of extension operators one can derive the
Sobolev inequalities in W 1,p(Ωǫ) with a constant independent of ǫ.
Lemma A.3 (Anisotropic Sobolev inequalities in perforated domains).









r1 ∈ [2,∞], q1 ∈ [2, 2NN−2 ] for N > 2
(116)
the following estimate holds
‖v‖Lr1 (0,T ;Lq1 (Ωǫ)) ≤ c ‖v‖Qǫ(T ) (117)
where c is a positive constant independent of ǫ and






















r2 ∈ [2,∞], q2 ∈ [2, 2(N−1)(N−2) ] for N ≥ 3
(119)
the following estimate holds




q2 ‖v‖Qǫ(T ) (120)
where c is a positive constant independent of ǫ and the norm ‖v‖Qǫ(T ) is defined as
in (118).
Proof.
(i) The extension Lemma A.2 ensures the well-definiteness of a linear continuous
extension operator Pǫ which satisfies (114) and (115). By the classical multiplicative
Sobolev inequalities valid in Ω (see [29] and [37]), we have that
‖Pǫv‖Lr1 (0,T ;Lq1 (Ω)) ≤ c1 ‖Pǫv‖Q(T ) (121)
where c1 ≥ 0 depends only on Ω, r1, q1, with r1 and q1 satisfying the conditions
(116) and











By using (114), (115) and (121), we conclude that
‖v‖Lr1 (0,T ;Lq1 (Ωǫ)) ≤ C ′ ‖Pǫv‖Lr1 (0,T ;Lq1 (Ω))
≤ C ′ c1 ‖Pǫv‖Q(T ) ≤ C ′ c1 C ‖v‖Qǫ(T )
(123)
where c := C ′ c1 C is independent of ǫ.


























where c1 ≥ 0 depends only on r2, q2 and on local properties of the surface ∂Ω (which
is assumed to be piecewise smooth) with r2 and q2 satisfying the conditions (119).



























































where c is a positive constant independent of ǫ.
B Appendix B
Let us introduce some definitions and results on two-scale convergence from [3,
4, 36], slightly modified to allow for homogenization with a parameter (the time t)
[14, 27, 34].
Definition B.1. A sequence of functions vǫ in L2([0, T ] × Ω) two-scale converges




















v0(t, x, y)φ(t, x, y) dt dx dy (127)
for all φ ∈ C1([0, T ] × Ω;C∞# (Y )).
The notion of ‘two-scale convergence’ makes sense because of the next compact-
ness theorem.
Theorem B.1. If vǫ is a bounded sequence in L2([0, T ] × Ω), then there exists a
function v0(t, x, y) in L
2([0, T ]×Ω×Y ) such that, up to a subsequence, vǫ two-scale
converges to v0.
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The following theorem is useful in obtaining the limit of the product of two two-
scale convergent sequences.
Theorem B.2. Let vǫ be a sequence of functions in L2([0, T ] × Ω) which two-scale














|v0(t, x, y)|2 dt dx dy (128)
Then, for any sequence wǫ in L2([0, T ] × Ω) that two-scale converges to a limit





















v0(t, x, y)w0(t, x, y)φ(t, x, y) dt dx dy
(129)
for all φ ∈ C1([0, T ] × Ω;C∞# (Y )).
The next theorems yield a characterization of the two-scale limit of the gradients
of bounded sequences vǫ. This result is crucial for applications to homogenization
problems.
We identify H1(Ω) = W 1,2(Ω), where the Sobolev space W 1,p(Ω) is defined by
W 1,p(Ω) =
{
v|v ∈ Lp(Ω), ∂v
∂xi
∈ Lp(Ω), i = 1, . . . , N
}
and we denote by H1#(Y ) the closure of C
∞
# (Y ) for the H
1-norm.
Theorem B.3. Let vǫ be a bounded sequence in L2(0, T ;H1(Ω)) that converges
weakly to a limit v(t, x) in L2(0, T ;H1(Ω)). Then, vǫ two-scale converges to v(t, x),
and there exists a function v1(t, x, y) in L
2([0, T ] × Ω;H1#(Y )/R) such that, up to a
subsequence, ∇vǫ two-scale converges to ∇xv(t, x) + ∇yv1(t, x, y).
Theorem B.4. Let vǫ and ǫ∇vǫ be two bounded sequences in L2([0, T ]×Ω). Then,
there exists a function v1(t, x, y) in L
2([0, T ]×Ω;H1#(Y )/R) such that, up to a subse-
quence, vǫ and ǫ∇vǫ two-scale converge to v1(t, x, y) and ∇yv1(t, x, y), respectively.
The main result of two-scale convergence can be generalized to the case of se-
quences defined in L2([0, T ] × Γǫ).
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|vǫ(t, x)|2 dt dσǫ(x) ≤ C (130)
where C is a positive constant, independent of ǫ. There exist a subsequence (still
denoted by ǫ) and a two-scale limit v0(t, x, y) ∈ L2([0, T ]×Ω;L2(Γ)) such that vǫ(t, x)





















v0(t, x, y)φ(t, x, y) dt dx dσ(y)
(131)
for any function φ ∈ C1([0, T ] × Ω;C∞# (Y )).
The proof of Theorem B.5 is very similar to the usual two-scale convergence
theorem [3]. It relies on the following lemma [4]:
Lemma B.1. Let B = C[Ω;C#(Y )] be the space of continuous functions φ(x, y) on
Ω × Y which are Y -periodic in y. Then, B is a separable Banach space which is





























|φ(x, y)|2 dx dσ(y). (133)
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[11] V. Chiadò Piat, S. S. Nazarov and A. L. Piatnitski, Steklov problems in perfo-
rated domains with a coefficient of indefinite sign. Networks And Heterogeneous
Media, 7(1): 151-178, 2012.
[12] D. Cioranescu and P. Donato, An introduction to homogenization . Oxford
University Press, Oxford, 1999.
[13] D. Cioranescu and J. Saint Jean Paulin, Homogenization of reticulated struc-
tures. Springer-Verlag, New York, 1999.
[14] G. W. Clark and R. E. Showalter, Two-scale convergence of a model for flow
in a partially fissured medium. Electronic Journal of Differential Equations,
1999(2): 1-20, 1999.
[15] C. Conca, On the application of the homogenization theory to a class of problems
arising in fluid mechanics. J. Math. pures et appl., 64: 31-75, 1985.
[16] L. Cruz, B. Urbanc, S. V. Buldyrev, R. Christie, T. Gómez-Isla, S. Havlin, M.
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